ArticlePloS one2025
The association between labor epidural analgesia and early-onset postpartum hypertension among parturients with hypertensive disorders of pregnancy: A retrospective cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidural Analgesia Duration and Postpartum Blood Pressure Trajectory in Hypertensive Pregnancies: A Time-to-Event Analysis.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the association of different durations of labor epidural analgesia (LEA) on early-onset postpartum hypertension (PPHTN) among parturients with hypertensive disorders of pregnancy (HDP).
methodsWe conducted a retrospective cohort study in which patients who were diagnosed with hypertensive disorders of pregnancy between 2018 and 2023. The parturients who received LEA were divided into three groups based on the tertiles of LEA duration: the short-duration group (< 175 minutes), the medium-duration group (175-324 minutes), and the long-duration group (≥ 325 minutes), while parturients who did not receive LEA forming the control group. The primary outcome was early-onset PPTHN, defined as the occurrence of at least one blood pressure measurement meeting hypertensive criteria within 2 days following delivery. Three multivariate logistic regression models was employed to explore the association between the duration of LEA exposure and early-onset PPHTN. Four sets of sensitivity analyses were conducted to assess the robustness of the analysis.
resultsIn the study cohort of 1,316 parturients, 36.0% (n = 474) were diagnosed with early-onset PPHTN. Compared with those who did not receive LEA, parturients who received long-exposure LEA had significantly lower incidences of early-onset PPHTN (29.5% vs 41.7%, P < 0.05). Univariate survival analysis demonstrated that long-duration LEA was associated with a lower risk of PPHTN during hospitalization (HR = 0.75, 95% CI: 0.59-0.95, P < 0.05). All three models showed long-exposure LEA exposure was associated with a reduced incidence of early-onset PPHTN among parturients with HDP. Consistent results were observed in the sensitivity analysis conducted among parturients with documented antepartum hypertension who received multiple antihypertensive medications during pregnancy, as well as among those who did not require antihypertensive therapy during the postpartum period. However, this association did not reach statistical significance when the follow-up period was extended to five days postpartum, or in subgroups of parturients with advanced maternal age, obesity, or PE.
conclusionA longer duration of LEA was associated with a reduced risk of early-onset PPHTN among women with HDP. However, this association did not reach statistical significance in subgroups of parturients with advanced maternal age, obesity, or PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.